Novel Biomarkers for Heart Disease

doi:10.3390/books978-3-03943-884-6

dc.contributor.editor	Lichtenauer, Michael
dc.date.accessioned	2021-05-01T15:49:57Z
dc.date.available	2021-05-01T15:49:57Z
dc.date.issued	2020
dc.identifier	ONIX_20210501_9783039438839_1197
dc.identifier.uri	https://directory.doabooks.org/handle/20.500.12854/69451
dc.description.abstract	Cardiac biomarkers such as troponins and natiuretic peptides have made a great impact on clinical decision making as well as improving our understanding of molecular mechanisms of different disease conditions. However, the biomarkers that are currently in use do not reflect all the multiple disease pathways that are involved in a broad spectrum of cardiac disease conditions ranging from acute coronary syndrome, to heart failure (and heart failure with preserved ejection fraction, HFpEF), to pulmonary hypertension or arrhythmias. In this Special Issue, we will provide an overview of the current developments in the field of biomarker research, beginning with research on molecular pathways and cellular communication (e.g., microRNA) up to the clinical use of biomarkers.
dc.language	English
dc.subject.classification	thema EDItEUR::M Medicine and Nursing	en_US
dc.subject.other	diet quality
dc.subject.other	ceramides
dc.subject.other	obesity
dc.subject.other	cardiovascular risk
dc.subject.other	healthy eating index
dc.subject.other	carbohydrate antigen-125
dc.subject.other	heart failure
dc.subject.other	inflammatory marker
dc.subject.other	older women
dc.subject.other	biomarker
dc.subject.other	cardiometabolic disease
dc.subject.other	epicardial adipose tissue
dc.subject.other	epicardial fat
dc.subject.other	epicardial fat volume
dc.subject.other	microRNA
dc.subject.other	thyroid-stimulating hormone
dc.subject.other	cardiometabolic risks
dc.subject.other	metabolic syndrome
dc.subject.other	hypertension
dc.subject.other	very low-density lipoprotein
dc.subject.other	STIM1
dc.subject.other	SOCE
dc.subject.other	atrial myopathy
dc.subject.other	atrial fibrillation
dc.subject.other	ejection fraction
dc.subject.other	soluble urokinase-type plasminogen activator receptor (suPAR)
dc.subject.other	growth differentiation factor 15 (GDF-15)
dc.subject.other	heart-type fatty acid-binding protein (H-FABP)
dc.subject.other	soluble suppression of tumorigenicity 2 (sST2)
dc.subject.other	acute myocardial infarction
dc.subject.other	biomarkers
dc.subject.other	catestatin
dc.subject.other	coronary artery disease
dc.subject.other	heart failure decompensation
dc.subject.other	left ventricular ejection fraction
dc.subject.other	troponin
dc.subject.other	NT-proBNP
dc.subject.other	NYHA functional class
dc.subject.other	GDF-15
dc.subject.other	cardiovascular surgery
dc.subject.other	operative risk
dc.subject.other	muscle wasting
dc.subject.other	sarcopenia
dc.subject.other	renal dysfunction
dc.subject.other	chronic kidney disease
dc.subject.other	aortic disease
dc.subject.other	aneurysm
dc.subject.other	miRNA
dc.subject.other	TGF-β pathway
dc.subject.other	KLF4
dc.subject.other	synthetic phenotype
dc.subject.other	aortic regurgitation
dc.subject.other	echocardiography
dc.subject.other	magnetic resonance imaging
dc.subject.other	vena contracta area
dc.subject.other	longitudinal strain
dc.subject.other	T1 mapping
dc.subject.other	GDF8
dc.subject.other	myostatin
dc.subject.other	AMI
dc.subject.other	ceruloplasmin
dc.subject.other	H-FABP
dc.subject.other	heart-type fatty acid-binding protein
dc.subject.other	FABP3
dc.subject.other	fatty acid-binding protein 3
dc.subject.other	HF
dc.subject.other	cardiac biomarkers
dc.subject.other	cardiac magnetic resonance imaging
dc.subject.other	left ventricular systolic function
dc.subject.other	magnetic resonance spectroscopy
dc.subject.other	myocardial triglyceride content
dc.subject.other	cell adhesion molecule
dc.subject.other	repeated measurements
dc.subject.other	pregnancy-associated plasma protein-A
dc.subject.other	cohort studies
dc.subject.other	cardiovascular diseases
dc.subject.other	mitochondrial dysfunction
dc.subject.other	circulating cells
dc.subject.other	PBMCS
dc.subject.other	platelets
dc.subject.other	oxidative stress
dc.subject.other	reactive oxygen species (ROS)
dc.subject.other	mitochondrial DNA (mtDNA)
dc.subject.other	herat failure
dc.subject.other	liver-type fatty-acid-binding protein
dc.subject.other	long-term outcomes
dc.subject.other	cardiac intensive care units
dc.subject.other	acute kidney injury
dc.subject.other	myocardial infarction
dc.subject.other	STEMI
dc.subject.other	cardiovascular events
dc.subject.other	cardiovascular death
dc.subject.other	risk stratification
dc.subject.other	sST2
dc.subject.other	Pentraxin-3
dc.subject.other	sudden cardiac death
dc.subject.other	ventricular arrhythmia
dc.subject.other	ventricular tachycardia
dc.subject.other	chronic heart failure
dc.subject.other	saliva
dc.subject.other	salivary biomarkers
dc.subject.other	CKD
dc.subject.other	CVD
dc.subject.other	PPCI
dc.subject.other	left ventricular adverse remodelling
dc.subject.other	circulating miRNAs
dc.subject.other	NAFLD
dc.subject.other	Framingham risk score
dc.subject.other	risk prediction
dc.subject.other	secondary prevention
dc.subject.other	primary prevention
dc.subject.other	NAFLD fibrosis score
dc.subject.other	HFpEF
dc.subject.other	HFrEF
dc.subject.other	suPAR
dc.subject.other	n/a
dc.title	Novel Biomarkers for Heart Disease
dc.type	book
oapen.identifier.doi	10.3390/books978-3-03943-884-6
oapen.relation.isPublishedBy	46cabcaa-dd94-4bfe-87b4-55023c1b36d0
oapen.relation.isbn	9783039438839
oapen.relation.isbn	9783039438846
oapen.pages	420
oapen.place.publication	Basel, Switzerland

Files in this item

Files	Size	Format	View
There are no files associated with this item.

This item appears in the following Collection(s)

Imported or submitted locally

Show simple item record

Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0/